Trade Zentalis Pharmaceuticals - ZNTL CFD
What is Zentalis Pharmaceuticals (ZNTL)?
Zentalis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer. The company specializes in developing targeted therapies that address underlying genetic drivers of cancer, with an emphasis on precision medicine approaches. Its research pipeline includes candidates aimed at various oncological indications, including solid tumors and hematological malignancies. Zentalis Pharmaceuticals employs a strategy that integrates medicinal chemistry, biology, and translational science to advance its drug candidates through clinical development. The company collaborates with academic institutions and industry partners to support its research efforts. Its operations encompass preclinical studies, clinical trials, and regulatory engagement to bring novel therapies to market.
Zentalis Pharmaceuticals Stock Price Today: Live Overview
The price today is shaped by market activity, with Zentalis Pharmaceuticals currently at $2.36. Its intraday range extends from $2.12 to $2.38 alongside a daily change percentage of +9.0047%.
FAQ: Zentalis Pharmaceuticals (ZNTL)
What is the current price of ZNTL stock?
Zentalis Pharmaceuticals is currently priced at $2.36.
Does ZNTL pay dividends?
The company does not pay dividends.
Does ZNTL have a formal corporate presence or regional headquarters in the UAE?
Zentalis Pharmaceuticals operates without an official regional office or subsidiary in the UAE and relies on partnerships for regional distribution.
What is ZNTL best known for?
It is most famous for developing oncology-focused small molecule therapeutics.
What assets are typically shown together with ZNTL?
Commonly shown alongside ZNTL: CSG N.V., iShares MSCI China ETF, DISC MEDICINE ORD
Latest shares articles



